NEW YORK – StageZero Life Sciences said on Monday it has expanded its five-year licensing deal with Oncore Pharma to add StageZero's BreastSentry and the Prostate Health Index to the drug firm's offering.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.